Upadacitinib for Moderate to Severe Hidradenitis Suppurativa Study in Kentucky
ENROLLING — This study will assess how safe and effective Upadacitinib is in treating adult and adolescent participants with moderate to severe HS.
Eltrekibart Study for Moderate to Severe Hidradenitis Suppurativa in Kentucky
ENROLLING — Be part of a clinical study in Kentucky evaluating the safety and efficacy of Eltrekibart for adults with moderate to severe Hidradenitis Suppurativa.
Lutikizumab Study for Moderate to Severe Hidradenitis Suppurativa in Kentucky
ENROLLING — Participate in a clinical trial in Kentucky evaluating the safety and efficacy of Lutikizumab for adults and adolescents with moderate to severe Hidradenitis Suppurativa.
Hidradenitis Suppurativa Clinical Trial With Remibrutinib in NYC
ENROLLING — Join our clinical trial in NYC for moderate-to-severe Hidradenitis Suppurativa (HS) with Remibrutinib. Help advance HS treatment while receiving expert care.